VytronUS rakes in $31.6 mln Series B
VytronUS, a Sunnyvale, Calif.-based medical device firm, has raised $31.6 million in Series B financing. The investors included Apple Tree Partners, BioStar Ventures, Windham Venture Partners and New Enterprise Associates. In addition to the funding, David McIntyre and Sami Hamade of Apple Tree Partners and Hank Kucheman of BioStar Ventures have been named to the VytronUS board of directors.
29 October 2014•4 mins read
